Advisory Services Network’s Niagen Bioscience NAGE Stock Holding History

Advisory Services Network’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185	Buy	+42	New	+$227	﹤0.01%	4576
2025 Q4	–	Sell	-792	Closed	-$7.39K	–	4490
2025 Q3	$7.39K	Buy	+792	New	+$8K	﹤0.01%	3399
2018 Q2	–	Sell	-1,500	Closed	-$6K	–	2724
2018 Q1	$6K	Hold	1,500	–	–	﹤0.01%	2070
2017 Q4	$9K	Hold	1,500	–	–	﹤0.01%	1894
2017 Q3	$6K	Buy	+1,500	New	+$5.48K	﹤0.01%	1841

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisory Services Network's NAGE Position: Q1 2026 in Review

Advisory Services Network opened a new position in Niagen Bioscience (NAGE) in Q1 2026: 42 shares worth $185. The stake represents ﹤0.01% of the portfolio and ranks #4576 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in NAGE as recently as Q3 2025.

Advisory Services Network first reported a position in NAGE in Q3 2017 and has held it in 5 quarters since. The position peaked at $9K in Q4 2017. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Advisory Services Network held 42 shares of Niagen Bioscience worth $185 as of Q1 2026.
Niagen Bioscience was a new Advisory Services Network position in Q1 2026.
Niagen Bioscience made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4576 holding.
Advisory Services Network first reported a position in Niagen Bioscience in Q3 2017 and has held it in 5 quarters since.
Advisory Services Network's Niagen Bioscience position peaked at $9K in Q4 2017.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.